Alexion Pharmaceuticals is a biopharmaceutical company that specializes in the development and commercialization of biologic therapeutic products. The company's focus is on products for severe and life-threatening diseases such as hematologic, kidney, and neurologic diseases, transplant rejection, cancer, and autoimmune disorders. The business operates in various regions worldwide, including the United States, Europe, Latin America, Japan, and the Asia Pacific.